Clinical Trial Update: Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of alteplase in Chinese patients with acute ischemic hemispheric stroke when thrombolysis is initiated between 3 and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Stroke | Phase 3 | Status: COMPLETED | Results posted: 2019-08-05